Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Oncology - Page 10

Oncology

Gilead Sciences acquired Calistoga Pharmaceuticals for $375 Million
Biotechnology | FDA | Life Science History | Oncology | Pharmaceutical | Therapeutics

Gilead Sciences acquired Calistoga Pharmaceuticals for $375 Million

On Feb. 22, 2011, Foster City, Calif-based Gilead Sciences and Calistoga Pharmaceuticals announced Gilead’s acquisition of Calistoga for…

Read More Gilead Sciences acquired Calistoga Pharmaceuticals for $375 MillionContinue

Jane and Lee Seidman donated $42 million to University Hospitals for Cancer Center
Biotechnology | Diagnostics | Disease | Non-Profit Research | Oncology | Radiology | Therapeutics

Jane and Lee Seidman donated $42 million to University Hospitals for Cancer Center

On Nov. 30, 2010, Jane and Lee Seidman have donated $42 million to University Hospitals (UH) – the…

Read More Jane and Lee Seidman donated $42 million to University Hospitals for Cancer CenterContinue

The Radiation Exposure Compensation Amendments of 1999 was signed into law
Biotechnology | Diagnostics | Disease | Life Science History | Oncology | Radiology | Therapeutics | U.S. Congress

The Radiation Exposure Compensation Amendments of 1999 was signed into law

On Jul. 7, 2010 the Radiation Exposure Compensation Amendments of 1999 (P.L. 106-245) was passed by the U.S….

Read More The Radiation Exposure Compensation Amendments of 1999 was signed into lawContinue

Siteman Cancer Center received NCI SPORE grant to study endometrial cancer
Biotechnology | Diagnostics | Disease | NIH | Non-Profit Research | Oncology | Women's Health

Siteman Cancer Center received NCI SPORE grant to study endometrial cancer

On Mar. 5, 2010, the National Cancer Institute (NCI) announced that it had awarded the Siteman Cancer Center…

Read More Siteman Cancer Center received NCI SPORE grant to study endometrial cancerContinue

Pacific Health Research & Education Institute became successor-in-interest to Pacific Health Research Institute
Biotechnology | Non-Profit Research | Oncology | Therapeutics

Pacific Health Research & Education Institute became successor-in-interest to Pacific Health Research Institute

In 2010, the Pacific Health Research & Education Institute (PHREI) became the successor-in-interest to Pacific Health Research Institute….

Read More Pacific Health Research & Education Institute became successor-in-interest to Pacific Health Research InstituteContinue

The Jon M Huntsman family donated $125 million to the Huntsman Cancer Institute
Biotechnology | Diagnostics | Non-Profit Research | Oncology | Therapeutics

The Jon M Huntsman family donated $125 million to the Huntsman Cancer Institute

On Apr. 26, 2000, Jon M. Huntsman, a billionaire industrialist, announced that he would give $125-million to a…

Read More The Jon M Huntsman family donated $125 million to the Huntsman Cancer InstituteContinue

Smilow Cancer Hospital opened for patient care
Biotechnology | Diagnostics | Oncology | Therapeutics

Smilow Cancer Hospital opened for patient care

On Oct. 26, 2009, the Smilow Cancer Hospital opened for patient care with María Rosa Menocal, a Yale…

Read More Smilow Cancer Hospital opened for patient careContinue

FDA approved new indication for gardasil to prevent genital warts in men and boys
Biotechnology | FDA | Infectious Disease | Oncology

FDA approved new indication for gardasil to prevent genital warts in men and boys

On Oct. 16, 2009, the U.S. Food and Drug Administration (FDA) approved new indication for gardasil to prevent…

Read More FDA approved new indication for gardasil to prevent genital warts in men and boysContinue

Dr. Brian Druker honored with Lasker Award
Biotechnology | Medicine | Non-Profit Research | Oncology | Therapeutics

Dr. Brian Druker honored with Lasker Award

On Sept. 16, 2009, Brian J. Druker, M.D.,whose research led to the development of Gleevec, the first targeted…

Read More Dr. Brian Druker honored with Lasker AwardContinue

Pfizer collaborated on landmark $6 million oncology research project with the Ontario Institute for Cancer Research
Biotechnology | Non-Profit Research | Oncology

Pfizer collaborated on landmark $6 million oncology research project with the Ontario Institute for Cancer Research

On Jul. 15, 2009, Pfizer with the Ontario Institute for Cancer Research (OICR) and the Ontario Cancer Institute…

Read More Pfizer collaborated on landmark $6 million oncology research project with the Ontario Institute for Cancer ResearchContinue

USC purchased  Norris Cancer Hospital and University Hospital (now Keck Hospital) from Tenet Healthcare
Biotechnology | Diagnostics | Medicine | Non-Profit Research | Oncology | Therapeutics

USC purchased Norris Cancer Hospital and University Hospital (now Keck Hospital) from Tenet Healthcare

On Apr. 1, 2009, the University of Southern California (USC) purchased Norris Cancer Hospital and University Hospital (now…

Read More USC purchased Norris Cancer Hospital and University Hospital (now Keck Hospital) from Tenet HealthcareContinue

The Hollings Cancer Center was designated a Cancer Institute
Biotechnology | Diagnostics | Non-Profit Research | Oncology | Therapeutics

The Hollings Cancer Center was designated a Cancer Institute

On Mar. 2, 2009, the Hollings Cancer Center was designated a Cancer Institute. National Cancer Institute (NCI) designation…

Read More The Hollings Cancer Center was designated a Cancer InstituteContinue

The Hollings Cancer Center received NCI-designation
Biotechnology | Diagnostics | Non-Profit Research | Oncology | Therapeutics

The Hollings Cancer Center received NCI-designation

On Mar. 2, 2009, the Hollings Cancer Center (HCC) received National Cancer Institute (NCI) designation. Hollings’ mission is…

Read More The Hollings Cancer Center received NCI-designationContinue

Emory University’s Chemical Biology Discovery Center became part of the NCI Chemical Biology Consortium (CBC)
Biotechnology | Chemical | Non-Profit Research | Oncology

Emory University’s Chemical Biology Discovery Center became part of the NCI Chemical Biology Consortium (CBC)

In Mar. 2009, Emory University’s Chemical Biology Discovery Center became part of the NCI Chemical Biology Consortium (CBC),…

Read More Emory University’s Chemical Biology Discovery Center became part of the NCI Chemical Biology Consortium (CBC)Continue

Lung oncology expert Alan Sandler, MD joined the Knight Cancer Institute
Biotechnology | Diagnostics | Oncology | Therapeutics

Lung oncology expert Alan Sandler, MD joined the Knight Cancer Institute

On Jan. 21, 2009, the Knight Cancer Institute announced the recruitment of lung oncology expert Alan Sandler, M.D.,…

Read More Lung oncology expert Alan Sandler, MD joined the Knight Cancer InstituteContinue

Surgeon Chris Amling, MD joined the Knight Cancer Institute
Medicine | Non-Profit Research | Oncology

Surgeon Chris Amling, MD joined the Knight Cancer Institute

On Jan. 20, 2009, the Knight Cancer Institute announced the recruitment of surgeon Chris Amling, M.D., chief of…

Read More Surgeon Chris Amling, MD joined the Knight Cancer InstituteContinue

Stanford researchers discovered the first human bladder cancer stem cell
Biotechnology | Disease | Non-Profit Research | Oncology | Stem Cell

Stanford researchers discovered the first human bladder cancer stem cell

On Aug. 3, 2009, Researchers at Stanford’s School of Medicine announced they had identified the first human bladder…

Read More Stanford researchers discovered the first human bladder cancer stem cellContinue

The University of New Mexico Cancer Center opened new state-of-the-art cancer treatment and research facility
Biotechnology | Diagnostics | Disease | Non-Profit Research | Oncology | Therapeutics

The University of New Mexico Cancer Center opened new state-of-the-art cancer treatment and research facility

In 2009, The University of New Mexico Cancer Center opened its new state-of-the-art cancer treatment and research facility….

Read More The University of New Mexico Cancer Center opened new state-of-the-art cancer treatment and research facilityContinue

The largest-ever prostate cancer prevention study showed that Selenium and Vitamin E do not help prevent prostate cancer
Biotechnology | Oncology | Therapeutics

The largest-ever prostate cancer prevention study showed that Selenium and Vitamin E do not help prevent prostate cancer

On Dec. 9, 2008, in contrast with earlier research suggesting that dietary supplementation with selenium and vitamin E…

Read More The largest-ever prostate cancer prevention study showed that Selenium and Vitamin E do not help prevent prostate cancerContinue

Siteman Cancer Center researchers sequenced the first human cancer genome from a patient was acute myeloid leukemia (AML)
Biotechnology | Genomics | Non-Profit Research | Oncology | Therapeutics

Siteman Cancer Center researchers sequenced the first human cancer genome from a patient was acute myeloid leukemia (AML)

On Nov. 5, 2008, Siteman Cancer Center and The Genome Center researchers Timothy J. Ley, MD, Elaine Mardis,…

Read More Siteman Cancer Center researchers sequenced the first human cancer genome from a patient was acute myeloid leukemia (AML)Continue

Philip and Penny Knight’s pledge $100 million to OHSU Cancer Institute
Biotechnology | Diagnostics | Non-Profit Research | Oncology | Radiology | Therapeutics

Philip and Penny Knight’s pledge $100 million to OHSU Cancer Institute

On Oct. 29, 2008, Oregon Health & Science University (OHSU) announced that Nike founder Philip H. and Penny…

Read More Philip and Penny Knight’s pledge $100 million to OHSU Cancer InstituteContinue

UGA received $8.3 million grant from the NIH to research stem cells and cancer cells
Biotechnology | NIH | Oncology | Stem Cell

UGA received $8.3 million grant from the NIH to research stem cells and cancer cells

On Oct. 8, 2008, the National Institutes of Health (NIH) announced it had awarded the University of Georgia…

Read More UGA received $8.3 million grant from the NIH to research stem cells and cancer cellsContinue

National Cancer Institute study provided clues about how cancer cells develop resistance to chemotherapy drug
Biotechnology | NIH | Non-Profit Research | Oncology

National Cancer Institute study provided clues about how cancer cells develop resistance to chemotherapy drug

On Sept. 14, 2008, the National Cancer Institute (NCI) researchers and colleagues have shown that increased expression of…

Read More National Cancer Institute study provided clues about how cancer cells develop resistance to chemotherapy drugContinue

Genetic region linked to a five times higher lung cancer risk
Biotechnology | Diagnostics | Genomics | Oncology | Therapeutics

Genetic region linked to a five times higher lung cancer risk

On Sept. 2008, a narrow region on chromosome 15 contains genetic variations strongly associated with familial lung cancer,…

Read More Genetic region linked to a five times higher lung cancer riskContinue

Stanford researchers discovered a molecule that kills kidney cancer cells
Biotechnology | Disease | Medicine | Oncology | Therapeutics

Stanford researchers discovered a molecule that kills kidney cancer cells

On Jul. 8, 2008, Stanford researchers announced discovered a molecule that kills kidney cancer cells. Ideally, the researchers…

Read More Stanford researchers discovered a molecule that kills kidney cancer cellsContinue

National Cancer Institute researchers found blocking a single protein proves toxic to myeloma cells in laboratory studies
Biotechnology | Diagnostics | Oncology | Therapeutics

National Cancer Institute researchers found blocking a single protein proves toxic to myeloma cells in laboratory studies

On Jun. 22, 2008, National Cancer Institute researchers announced that cells from a blood-borne cancer called multiple myeloma…

Read More National Cancer Institute researchers found blocking a single protein proves toxic to myeloma cells in laboratory studiesContinue

Hutch scientists put advanced cancerous tumor into long-term remission by reprogramming patient’s T cells
Biotechnology | Disease | Non-Profit Research | Oncology | Therapeutics

Hutch scientists put advanced cancerous tumor into long-term remission by reprogramming patient’s T cells

On Jun. 18, 2008, Fred Hutch researchers described the first successful use of a human patient’s cloned infection-fighting…

Read More Hutch scientists put advanced cancerous tumor into long-term remission by reprogramming patient’s T cellsContinue

The Breast Cancer and Environmental Research Act of 2007 authorized NIEHS Director to make grants for development of research centers
Biotechnology | Diagnostics | Environmental | Oncology | U.S. Congress

The Breast Cancer and Environmental Research Act of 2007 authorized NIEHS Director to make grants for development of research centers

On May 13, 2008, the U.S. Congress passed the Breast Cancer and Environmental Research Act which amended the…

Read More The Breast Cancer and Environmental Research Act of 2007 authorized NIEHS Director to make grants for development of research centersContinue

National Cancer Institute mouse studies identified gene that may influence metastasis risk in breast cancer
Biotechnology | Diagnostics | Disease | Genomics | NIH | Oncology | Therapeutics

National Cancer Institute mouse studies identified gene that may influence metastasis risk in breast cancer

On Apr. 29, 2008, National Cancer Institute (NCI) researchers identified a pattern of gene activity in mice that…

Read More National Cancer Institute mouse studies identified gene that may influence metastasis risk in breast cancerContinue

National Cancer Institute study of mutations in Non-Hodgkin lymphoma yielded clues for potential new therapies
Biotechnology | Diagnostics | Genomics | Oncology | Therapeutics

National Cancer Institute study of mutations in Non-Hodgkin lymphoma yielded clues for potential new therapies

On Mar. 6, 2008, DNA mutations found in a type of non-Hodgkin lymphoma that has a poor prognosis…

Read More National Cancer Institute study of mutations in Non-Hodgkin lymphoma yielded clues for potential new therapiesContinue

Page navigation

Previous PagePrevious 1 … 8 9 10 11 12 … 26 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search